respirerx.jpg
RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
December 05, 2022 08:30 ET | RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Dec. 05, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Markets: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
IOSP Logo.jpg
Innospec Secures Land for Future Expansion at its Primary Personal Care Manufacturing Facility
July 28, 2022 09:15 ET | Innospec Inc.
ENGLEWOOD, Colo., July 28, 2022 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announces the purchase of land which significantly increases the acreage available for future expansion at its...
Exxact Corporation Releases New GRAID SupremeRAID™ Powered NVMeoF Storage Solution for AI and HPC Workloads
June 14, 2022 10:00 ET | GRAID Technology
SANTA CLARA, Calif., June 14, 2022 (GLOBE NEWSWIRE) --  Exxact Corporation, a North America-based leading provider of high-performance computing (HPC), artificial intelligence (AI), and data center...
respirerx.jpg
Letter to Stockholders and Other Stakeholders: A Brief Summary of Our Progress During Past Twelve Months and a Peek Looking Forward
March 07, 2022 08:00 ET | RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., March 07, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
image1.png
Shaw Announces First Quarter Fiscal 2022 Results
January 12, 2022 08:00 ET | Shaw Communications Inc.
First quarter consolidated financial results include adjusted EBITDA1 growth of 4.3% and free cash flow1 of $236 million The Company continues to focus on balancing growth and profitability and...
respirerx.jpg
RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
November 29, 2021 08:45 ET | RespireRX Pharmaceuticals Inc.
Glen Rock, N.J.,, Nov. 29, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
respirerx.jpg
RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO 
November 04, 2021 08:45 ET | RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Nov. 04, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI), (“RespireRx” or the “Company”) a leader in the discovery and development of innovative and...
IOSP Logo.jpg
Innospec Expands Mild, Natural, Sulfate-Free Performance Chemicals Manufacturing Capacity
July 06, 2021 09:15 ET | Innospec Inc.
ENGLEWOOD, Colo., July 06, 2021 (GLOBE NEWSWIRE) -- To meet accelerating demand for its innovative, industry-leading, mild and sustainability-focused surfactants, Innospec has announced further...
respirerx.jpg
RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
January 05, 2021 16:05 ET | RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company” or “we”), has, on January 4, 2021, filed with the Secretary of State of...
respirerx.jpg
RespireRx Pharmaceuticals Inc. Announces Extension to Long-Term Employment Contract with Tim Jones as President and Chief Executive Officer
August 03, 2020 15:11 ET | RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC: RSPI) (“RespireRx” or the “Company”), is pleased to announce that today, Mr. Tim Jones and RespireRx have...